FR2468372B1 - - Google Patents

Info

Publication number
FR2468372B1
FR2468372B1 FR8022285A FR8022285A FR2468372B1 FR 2468372 B1 FR2468372 B1 FR 2468372B1 FR 8022285 A FR8022285 A FR 8022285A FR 8022285 A FR8022285 A FR 8022285A FR 2468372 B1 FR2468372 B1 FR 2468372B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8022285A
Other languages
French (fr)
Other versions
FR2468372A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2468372A1 publication Critical patent/FR2468372A1/fr
Application granted granted Critical
Publication of FR2468372B1 publication Critical patent/FR2468372B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8022285A 1977-09-30 1980-10-17 Nouveau vaccin contre les maladies infectieuses chez les bovins et son procede de production Granted FR2468372A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11842677A JPS5452794A (en) 1977-09-30 1977-09-30 Extracting of polysacchride from capusle containing epidermis staphylococus

Publications (2)

Publication Number Publication Date
FR2468372A1 FR2468372A1 (fr) 1981-05-08
FR2468372B1 true FR2468372B1 (enExample) 1983-10-14

Family

ID=14736342

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7828133A Granted FR2410043A1 (fr) 1977-09-30 1978-10-02 Nouveau vaccin contre la mammite de la vache et son procede de production
FR8022285A Granted FR2468372A1 (fr) 1977-09-30 1980-10-17 Nouveau vaccin contre les maladies infectieuses chez les bovins et son procede de production

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7828133A Granted FR2410043A1 (fr) 1977-09-30 1978-10-02 Nouveau vaccin contre la mammite de la vache et son procede de production

Country Status (4)

Country Link
US (1) US4197290A (enExample)
JP (1) JPS5452794A (enExample)
FR (2) FR2410043A1 (enExample)
GB (1) GB2009771B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327082A (en) * 1979-07-12 1982-04-27 Adcock-Ingram Laboratories Limited Mastitis vaccination
US4425330A (en) 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4762712A (en) * 1983-08-31 1988-08-09 Stolle Research & Development Corporation Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
DE3345864A1 (de) * 1983-12-19 1985-06-27 Egbert Frh. von 8000 München Malsen-Ponickau Impfstoff und verfahren zu seiner herstellung
JPS62165286U (enExample) * 1986-04-07 1987-10-20
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
US5034515A (en) * 1987-09-22 1991-07-23 Wisconsin Alumni Research Foundation Staphylococcal fibronectin receptor, monoclonal antibodies thereto and methods of use
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US20080139789A1 (en) * 1990-10-22 2008-06-12 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
US5955074A (en) * 1990-10-22 1999-09-21 Henry M. Jackson Foundation For The Advancement Of Military Medicine Directed human immune globulin for the prevention and treatment of staphylococcal infections
AU681573B2 (en) * 1991-11-22 1997-09-04 Glaxosmithkline Biologicals Sa Type I and type II surface antigens associated with (staphylococcus epidermidis)
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
EP0628056A4 (en) * 1992-02-25 1997-03-05 Jackson H M Found Military Med TARGETED HUMAN IMMUNGLOBULINE TO PREVENT AND TREAT STAPHYLOCOCCEN INFECTIONS.
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
EP1583517B1 (en) 2002-11-12 2019-06-12 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
NZ539153A (en) 2002-11-12 2006-11-30 Brigham & Womens Hospital Polysaccharide vaccine for staphylococcal infections
US7786255B2 (en) 2004-04-21 2010-08-31 The Bringham and Women's Hospital, Inc. Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
JP2008513406A (ja) 2004-09-22 2008-05-01 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
BRPI0710210A2 (pt) 2006-03-30 2011-05-24 Glaxomithkline Biolog S A composição imunogênica, vacina, métodos para preparar a vacina, e para prevenir ou tratar infecção estafilocócica, uso da composição imunogênica, e, processo para conjugar oligassacarìdeo ou polissacarìdeo capsular
NZ591103A (en) 2008-07-21 2013-02-22 Brigham & Womens Hospital Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
JP2012504660A (ja) 2008-10-06 2012-02-23 ユニバーシティ オブ シカゴ 細菌ｅａｐ、ｅｍｐおよび／またはａｄｓａタンパク質に関連する組成物および方法
RU2403283C2 (ru) * 2008-12-30 2010-11-10 Общество с ограниченной ответственностью "БиоМедВет" Штамм staphylococcus epidermidis bvm-1987 - продуцент стафилолитического ферментного комплекса
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
MX373250B (es) 2009-09-30 2020-05-04 Glaxosmithkline Biologicals S A Star Conjugación de polisacáridos capsulares de tipo 5 y de tipo 8 de staphylococcus aureus.
US9060965B2 (en) 2009-10-30 2015-06-23 Glaxosmithkline Biologicals Sa Purification of Staphylococcus aureus type 5 capsular saccharides
CA2860331A1 (en) 2010-12-24 2012-06-28 Novartis Ag Compounds
CN103917245B (zh) 2011-09-14 2017-06-06 葛兰素史密丝克莱恩生物有限公司 用于制备糖‑蛋白质糖缀合物的方法
EP2776069A1 (en) 2011-11-07 2014-09-17 Novartis AG Carrier molecule comprising a spr0096 and a spr2021 antigen
GB201121301D0 (en) 2011-12-12 2012-01-25 Novartis Ag Method
BR112014029313A2 (pt) 2012-05-22 2017-06-27 Novartis Ag conjugado de meningococos do sorogrupo x
EP3735268A4 (en) * 2018-01-05 2021-12-22 Azitra, Inc. AUXOTROPICAL STRAINS OF STAPHYLOCOCCUS BACTERIA
WO2020163512A1 (en) 2019-02-05 2020-08-13 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278429A (enExample) * 1900-01-01
NL262599A (enExample) * 1900-01-01
GB925124A (en) * 1960-03-21 1963-05-01 Parke Davis & Co Staphylococcal vaccine
DE1154234B (de) * 1960-03-21 1963-09-12 Parke Davis & Co Verfahren zur Herstellung einer Staphylococcenvaccine
FR1334930A (fr) * 1961-03-20 1963-08-16 Parke Davis & Co Procédé de production d'un antigène nouveau par extraction de culture de staphylocoques
DK105490C (da) * 1961-05-15 1966-10-03 Parke Davis & Co Fremgangsmåde til fremstilling af et stafylokok-antigenprodukt i form af immunogene polysaccharidforbindelser.
US3269913A (en) * 1962-05-11 1966-08-30 Parke Davis & Co Staphylococcal-immunizing products and methods for their production
GB995338A (en) * 1963-09-20 1965-06-16 Parke Davis & Co Polysaccharides and methods for their production
JPS5520268B2 (enExample) * 1972-07-15 1980-05-31

Also Published As

Publication number Publication date
FR2410043B1 (enExample) 1983-09-09
FR2410043A1 (fr) 1979-06-22
GB2009771B (en) 1982-07-14
JPS5452794A (en) 1979-04-25
US4197290A (en) 1980-04-08
JPS5611436B2 (enExample) 1981-03-14
GB2009771A (en) 1979-06-20
FR2468372A1 (fr) 1981-05-08

Similar Documents

Publication Publication Date Title
FR2410043B1 (enExample)
DE2842362C3 (enExample)
FR2377531B1 (enExample)
FR2378719B1 (enExample)
FR2378669B3 (enExample)
FR2377812B1 (enExample)
FR2378959B1 (enExample)
FR2377703B1 (enExample)
FR2377022B2 (enExample)
FR2378662B1 (enExample)
DE2743554C2 (enExample)
FR2377584B3 (enExample)
DE2753111C2 (enExample)
BG25845A1 (enExample)
BG25829A1 (enExample)
BG25855A1 (enExample)
BG25853A1 (enExample)
BG25852A1 (enExample)
BG26151A1 (enExample)
BG25851A1 (enExample)
BG25848A1 (enExample)
BG25847A1 (enExample)
BG25850A1 (enExample)
BG25844A1 (enExample)
BG25841A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse